| Theme | Diagnostic and Interventional EUS -- Present Status and Future Perspectives | |
|---|---|---|
| Title | Anti-tumor Therapy Employing EUS-FNA | |
| Publish Date | 2013/12 | |
| Author | Atsushi Irisawa | Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University |
| Author | Goro Shibukawa | Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University |
| Author | Yoko Abe | Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University |
| Author | Akiko Nikaido | Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University |
| Author | Koh Imbe | Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University |
| Author | Koki Hoshi | Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University |
| Author | Akane Yamabe | Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University |
| [ Summary ] | Interventional EUS is aggressively performed not only as a diagnostic but also as a therapeutic procedure. Recently, some kinds of EUS-guided therapy for various gastrointestinal diseases have been investigated in clinical trials and/or experimental studies. EUS-guided therapy for neoplasms has been particularly examined. EUS-guided therapy is divided into two categories, fine needle injection of ethanol, or cytoimplant and ablation using special radiofrequency devices. It may be possible to expand EUS-guided therapy as a treatment for various digestive neoplasms. | |